Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Wegovy is indicated for people ages 12 years and older who have: A BMI of 30 kg/m 2 or higher A BMI of 27 kg/m 2 to 29.9 kg/m 2 and at least one weight-related comorbidity , such as high blood pressure, type 2 diabetes, or obstructive sleep apnea Wegovy is also indicated to reduce the risk of major cardiovascular events , such as heart attack or stroke, in people who have obesity or overweight
The typical requirements for coverage are: FDA-approved medical condition: Ozempic is usually only covered as a treatment for certain conditions, such as: To improve blood sugar control in adults with type 2 diabetes To reduce the risk of stroke and heart attack in those with type 2 diabetes and established heart disease To reduce the risk of kidney function decline in those with type 2 diabetes and chronic kidney disease
Toujeo does carry a somewhat lower hypoglycemia risk compared to Lantus, thanks to its more gradual absorption profile
Many people starting Wegovy also begin or intensify exercise regimens as part of their weight management plan
Jones Simmer said that insurers and employers are taking multiple approaches to address this issue, from leaning more closely on their pharmacy benefit managers to outright dropping coverage options
